Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.50
Delayed Data
As of Oct 20
 +0.01 / +0.29%
Today’s Change
1.93
Today|||52-Week Range
3.77
+65.09%
Year-to-Date

Today’s Trading

Previous close3.49
Today’s open3.50
Day’s range3.46 - 3.53
Volume1,087,370
Average volume (3 months)1,743,340
Market cap$539.3M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-80.79%
Earnings growth (this year)+56.41%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-59.03%
P/E ratio8.0
Price/Sales1.45
Price/Book0.77

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc+0.17+3.85%
ATRAAtara Biotherapeutic...+0.25+1.74%
CYADCelyad SA+0.99+1.61%
BCRXBioCryst Pharmaceuti...-0.30-5.88%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$239.7M
Annual profit (last year)$63.6M
Net profit margin26.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John Peter McLaughlin
President
Dominique Monnet
Corporate headquarters
Incline Village, Nevada

Forecasts